This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Rising on Monster Volume

Myriad Genetics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Myriad Genetics (MYGN - Get Report) is a molecular diagnostic company. Myriad Genetics is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of the molecular diagnostic testing and analysis for its tests in its own reference laboratory. This stock is trading up 5% at $23.94 in recent trading.

Today's Volume: 1.3 million

Average Volume: 664,112

Volume % Change: 284%

Shares of MYGN are ripping higher today after the Supreme Court made a decision to remand back to the Court of Appeals Federal Circuit a patent case between ACLU and Myriad Genetics.

From a technical perspective, MYGN are rising sharply today back above its 50-day moving average of $23.59 on heavy volume.

Traders should now look for more upside and long biased trades if MYGN can take out some near-term overhead resistance around $24.50 with high-volume. Look for volume on that move that's near or well above 664,112 shares. If we get that action today or soon, then look for MYGN to re-test its recent high of $25.75.

Myriad shows up on a list of 4 Upgraded, Undervalued Stocks.
2 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
KIOR $0.01 -3.45%
ASGN $36.24 0.50%
BWLD $136.91 2.43%
FINL $19.85 0.51%
MYGN $36.66 1.83%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs